New laser could spark hair regrowth in balding patients

NCT ID NCT05460611

Recruiting now Disease control Sponsor: Montefiore Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a 1470nm laser on 10 adults with androgenetic alopecia (common baldness) or scarring alopecia. Researchers will measure hair density and counts using imaging, and track satisfaction. The goal is to see if the laser is safe and can improve hair growth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 1470nm non-ablative laser
What this could lead to: If it works, this could offer a new, non-drug option to improve hair density in people with common or scarring hair loss.
What could go wrong: This is a very small pilot study with only 10 people, so results may not apply to everyone. The laser may not work or could cause side effects like skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANDROGENETIC ALOPECIA SCARRING ALOPECIA

Contacts and locations

Locations

Montefiore Einstein Advanced Care
RECRUITING

Elmsford, New York, 10523, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.